icon-folder.gif   Conference Reports for NATAP  
  53rd ICAAC Interscience Conference on
Antimicrobial Agents and Chemotherapy
September 10-13, 2013, Denver CO
Back grey_arrow_rt.gif
Identifying High Responder Populations to Crofelemer for Treatment of Noninfectious Diarrhea in HIV+ Individuals
  Reported by Jules Levin
ICAAC 2013 Sept 10-13 Denver, CO
Rodger D. MacArthur, MD1; Patrick G. Clay, PharmD2; Andrew C. Barrett, PhD3; Pamela L. Golden, PhD3; Enoch Bortey, PhD3; Craig Paterson, MD3; William P. Forbes, PharmD3 1Wayne State University, Detroit, MI, USA; 2University of North Texas System College of Pharmacy, Fort Worth, TX, USA; 3Salix Pharmaceuticals, Inc., Raleigh, NC, USA
ICAAC: Crofelemer Effective for Severe or PI-Related Diarrhea in Placebo Trial - Written by Mark Mascolini - (09/12/13)